KalVista Pharmaceuticals Inc (KALV)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David M. Renzi
Employees:
45
ONE KENDALL SQUARE, BUILDING 200, STE. 2203, CAMBRIDGE, MA 02139
(857) 999-0075

Carbylan Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of novel and proprietary combination therapies.

Data derived from most recent annual or quarterly report
Market Cap 400.292 Million Shares Outstanding24.438 Million Avg 30-day Volume 235.265 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 45.0 / 14.33 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from KALV instead.

View recent insider trading info

Funds Holding KALV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KALV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

10 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CROCKETT THOMAS ANDREW CEO

  • Officer
  • Director
124,670 2021-10-01 10

PEREIRA BRIAN JG

  • Director
10,000 2021-09-30 1

UNKART EDWARD W

  • Director
10,000 2021-09-30 1

SOLAND DANIEL B

  • Director
10,000 2021-09-30 1

CHA ALBERT

  • Director
10,000 2021-09-30 2

EDWARDS MARTIN

  • Director
10,000 2021-09-30 1

FEENER EDWARD P. CHIEF SCIENTIFIC OFFICER

  • Officer
8,234 2021-08-02 9

YEA CHRISTOPHER CHIEF DEVELOPMENT OFFICER

  • Officer
37,969 2021-08-02 7

SMITH MICHAEL DAVID SENIOR VP, DEVELOPMENT

  • Officer
22,596 2021-06-01 5

PALLEIKO BENJAMIN L CFO, CBO & SECRETARY

  • Officer
75,000 2021-05-26 5

MAETZEL ANDREAS SENIOR VICE PRESIDENT, MEDICAL

  • Officer
25,000 2021-05-26 4

AUDHYA PAUL K. CHIEF MEDICAL OFFICER

  • Officer
0 2021-05-01 2

STUART NANCY

  • Director
0 2021-03-18 2

ORONSKY ARNOLD L

  • Director
0 2020-10-01 0

SVLSF IV, LLC

SV LIFE SCIENCES FUND IV (GP), L.P.

SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.

SV LIFE SCIENCES FUND IV, L.P.

  • 10% Owner
No longer subject to file 2019-04-08 0

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VHCP CO-INVESTMENT HOLDINGS II, LLC

VHCP MANAGEMENT II, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.

VHCP CO-INVESTMENT HOLDINGS III, LLC

VHCP MANAGEMENT III, LLC

KOH BONG Y

SHAH NIMISH P

  • 10% Owner
No longer subject to file 2019-03-18 0

ALDRICH RICHARD

  • Director
0 2018-10-03 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

  • Director
  • 10% Owner
1,441,070 2017-10-12 0

SHAH RAJEEV M.

  • Director
  • 10% Owner
1,441,070 2017-10-12 0

NOVO HOLDINGS A/S

  • 10% Owner
No longer subject to file 2017-10-10 0

RESNICK JOSHUA

  • Director
0 2017-09-27 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • Director
  • 10% Owner
0 2016-11-21 0

BASTA STEVEN L

  • Director
No longer subject to file 2016-11-21 0

RENZI DAVID PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2016-11-21 0

MARONEY MARCEE VP, CLINICAL AFFAIRS

  • Officer
No longer subject to file 2016-11-21 0

SAUL DAVID JOSEPH

  • Director
0 2016-02-01 0

GRAVETT DAVID M. VP, RESEARCH & DEVELOPMENT

  • Officer
0 2016-01-04 0

RAMIYA PREMCHANDRAN VICE PRESIDENT OF SUPPLY CHAIN

  • Officer
0 2016-01-04 0

MCKUNE JOHN SEE REMARKS

  • Officer
0 2016-01-04 0

CLAPPER DAVID M

  • Director
0 2015-08-03 0

KATKIN KEITH

  • Director
0 2015-08-03 0

LEWIS HAYLEY SEE REMARKS

  • Officer
0 2015-08-03 0

ZADNO REZA

  • Director
0 2015-08-03 0

ACMP IV LLC

ACP IV, L.P.

JANNEY DANIEL

  • 10% Owner
4,343,550 2015-04-14 0

NOHRA GUY P

  • Director
4,343,550 2015-04-14 0

INTERWEST MANAGEMENT PARTNERS IX, LLC

INTERWEST PARTNERS IX, LP

GIANOS PHILIP T

ORONSKY ARNOLD L

KLIMAN GILBERT H

HOLMES W STEPHEN

KJELLSON NINA S

PEPPER DOUGLAS A

CLEVELAND BRUCE A

NASR KHALED

  • 10% Owner
4,619,196 2015-04-14 0

VIVO VENTURES VI, LLC

VIVO VENTURES FUND VI, L.P.

VIVO VENTURES VI AFFIILATES FUND, L.P.

  • 10% Owner
4,204,564 2015-04-14 0

WHITE THOMAS MICHAEL SEE REMARKS

  • Officer
0 2015-04-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CROCKETT THOMAS ANDREW - Director - Officer CEO

2021-10-04 16:57:20 -0400 2021-10-01 S 10,000 $17.18 d 124,670 direct yes 0.4147 5.9834 5.9834 6 0.0 1

PEREIRA BRIAN JG - Director

2021-10-01 16:55:16 -0400 2021-09-30 A 10,000 a 10,000 direct

UNKART EDWARD W - Director

2021-10-01 16:58:32 -0400 2021-09-30 A 10,000 a 10,000 direct

EDWARDS MARTIN - Director

2021-10-04 16:53:55 -0400 2021-09-30 A 10,000 a 10,000 direct

CHA ALBERT - Director

2021-10-01 16:53:10 -0400 2021-09-30 A 10,000 a 10,000 direct

SOLAND DANIEL B - Director

2021-10-01 16:56:56 -0400 2021-09-30 A 10,000 a 10,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 22:15:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 21:45:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 21:15:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 20:45:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 20:15:04 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 19:45:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 19:15:04 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 18:45:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 18:15:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 17:45:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 17:15:04 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 16:45:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 16:15:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 15:45:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 15:15:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 14:45:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 14:15:04 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 13:45:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 13:15:03 UTC -0.18 0.25 200000
KALVISTA PHARMACEUTICALS INC KALV 2021-10-27 12:45:03 UTC -0.18 0.25 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments